1.Lips, P. Worldwide status of vitamin D nutrition. J Steroid Biochem Mol Biol. 2010; 121, 297–300.
2.Bowyer, L, Catling-Paul, C, Daimond, T, et al. Vitamin D, PTH and calcium levels in pregnant women and their neonates. Clin Endocrinol. 2009; 70, 372–377.
3.Dawodu, A, Wagner, CL. Mother–child vitamin D deficiency: an international perspective. Arch Dis Child. 2007; 92, 737–740.
4.Johnson, JA, Grande, JP, Roche, PC, et al. 1 alpha, 25-dihydroxyvitamin D3 receptor ontogenesis in fetal renal development. Am J Physiol Renal Physiol. 1995; 269, F419–F428.
5.Yuan, W, Pan, W, Kong, J, et al. 1,25-dihydroxyvitamin D3 suppresses renin gene transcription by blocking the activity of the cyclic AMP response element in the renin gene promoter. J Biol Chem. 2007; 282, 29821–29830.
6.Li, YC, Kong, J, Wei, M, et al. 1,25-dihydroxyvitamin D3 is a negative endocrine regulator of the renin–angiotensin system. J Clin Invest. 2002; 110, 229–238.
7.Zhou, C, Lu, F, Cao, K, et al. Calcium-independent and 1,25(OH)2D3-dependent regulation of the renin–angiotensin system in 1α-hydroxylase knockout mice. Kidney Int. 2008; 74, 170–179.
8.Nguyen, G, Delarue, F, Burcklé, C, et al. Pivotal role of the renin/prorenin receptor in angiotensin II production and cellular responses to renin. J Clin Invest. 2002; 109, 1417–1427.
9.Huang, Y, Wongamorntham, S, Kasting, J, et al. Renin increases mesangial cell TGF–β1 and matrix proteins through receptor-mediated, angiotensin II-independent mechanisms. Kidney Int. 2006; 69, 105–113.
10.Welsh, WI, Saleem, MA. Nephrin – signature molecule of the glomerular podocyte? J Pathol. 2010; 220, 328–337.
11.Deb, DK, Wang, Y, Zhang, Z, et al. Molecular mechanism underlying 1,25-dihydroxyvitamin D regulation of nephrin gene expression. J Biol Chem. 2011; 286, 32011–32017.
12.Guron, G, Friberg, P. An intact renin–angiotensin system is a prerequisite for normal renal development. J Hypertens. 2000; 18, 123–137.
13.Moritz, KM, Wintour, EM, Black, MJ, Bertram, JF, Caruna, G. Factors influencing mammalian kidney development: implications for health in adult life. Adv Anat Embryol Cell Biol. 2008; 196, 1–78.
14.Vehaskari, VM, Woods, LL. Prenatal programming of hypertension: lessons from experimental models. J Am Soc Nephrol. 2005; 16, 2545–2556.
15.Maka, N, Makrakis, J, Parkington, HC, et al. Vitamin D deficiency during pregnancy and lactation stimulates nephrogenesis in rat offspring. Pediatr Nephrol. 2008; 23, 55–61.
16.Gezmish, O, Tare, M, Parkington, HC, et al. Maternal Vitamin D deficiency leads to cardiac hypertrophy in rat offspring. Reprod Sci. 2010; 17, 168–176.
17.Tare, M, Emmett, SJ, Coleman, HA, et al. Vitamin D insufficiency is associated with impaired vascular endothelial and smooth muscle function and hypertension in young rats. J Physiol. 2011; 19, 4777–4786.
18.Nascimento, FAM, Ceciliano, TC, Aguila, MB, Mandarim-de-Lacerda, CA. Maternal vitamin D deficiency delays glomerular maturity in F1 and F2 offspring. PLoS One. 2012; 7(8), e41740.
19.Rogers, SA, Droege, D, Dusso, A, Hammerman, MR. Incubation of metanephroi with Vitamin D3 increases number of glomeruli. Organogenesis. 2004; 1, 52–54.
20.Weishaar, RE, Simpson, RU. Vitamin D3 and cardiovascular function in rats. J Clin Invest. 1987; 79, 1706–1712.
21.Haeckel, R. Simplified determinations of the ‘true’ creatinine concentration in serum and urine. J Clin Chem Clin Biochem. 1980; 18, 385–394.
22.Lowry, OH, Rosebrough, NJ, Farr, LA, Randall, RJ. Protein measurement with the Folin reagent. J Biol Chem. 1951; 193, 265–275.
23.Zhang, Z, Zhang, Y, Ning, G, et al. Combination therapy with AT1 blocker and vitamin D analog markedly ameliorates diabetic nephropathy: Blockade of compensatory renin increase. Proc Natl Acad Sci USA. 2008; 105, 15896–15901.
24.Weng, S, Sprague, JE, Jisu, O, et al. Vitamin D Deficiency Induces High Blood Pressure and Accelerates Atherosclerosis in Mice. PLoS One. 2013; 8, e54625.
25.Gomez, RA, Lynch, KR, Sturgill, BC, et al. Distribution of renin mRNA and its protein in the developing kidney. Am J Physiol Renal Physiol. 1989; 257, F850–F858.
26.Castrop, H, Hocherl, K, Kurtz, A, et al. Physiology of kidney renin. Physiol Rev. 2010; 90, 607–673.
27.Kobori, H, Nangaku, M, Navar, LG, Nishiyama, A. The intrarenal renin–angiotensin system: From physiology to the pathobiology of hypertension and kidney disease. Pharmacol Rev. 2007; 59, 251–287.
28.Stevens, LA, Coresh, J, Greene, T, Levey, AS. Assessing kidney function – measured and estimated glomerular filtration rate. N Engl J Med. 2006; 354, 2473–2483.
29.Kong, J, Zhang, Z, Li, D, et al. Loss of vitamin D receptor produces polyuria by increasing thirst. J Am Soc Nephrol. 2008; 19, 2396–2405.
30.Eyles, DW, Feron, F, Cui, X, et al. Developmental vitamin D deficiency causes abnormal brain development. Psychoneuroendocrinology. 2009; 34(Suppl 1), S247–S257.
31.Boldo, A, Campbell, P, Luthra, P, White, WB. Should the concentration of vitamin D be measured in all patients with hypertension? J Clin Hypertens. 2010; 12, 149–152.
32.Narvaez, CJ, Matthews, D, Broun, E, Chan, M, Welsh, JE. Lean phenotype and resistance to diet-induced obesity in vitamin D receptor knockout mice correlates with induction of uncoupling protein-1 in white adipose tissue. Endocrinology. 2009; 150, 651–661.